December 26, 2018
Myriad Genetics’ adjusted blood test Vectra DA outshouts typical measures in predicting new joint damage in RA patients
Myriad Genetics’ study results on development of the adjusted Vectra, announced Wednesday, found it outperforming typical measures of disease activity in predicting new joint damage in rheumatoid arthritis patients.